Quick answerRespond to
linaclotide-associated severe diarrhea and hypoperfusion.
Why this is correctPostmarketing severe diarrhea has been associated with syncope, hypotension, and electrolyte abnormalities requiring hospitalization or intravenous fluids.
Easy analogy or mental pictureUse a closed medication-safety loop: identify the exposure, connect the new findings, interrupt further harm, support physiology, and verify the response over time.
Memory hookExposure, interaction, toxicity pattern, immediate action, serial reassessment.NCLEX decision ruleChoose the action that reduces the most immediate medication-related risk while preserving monitoring and escalation.
Why the other choices are wrongOptions that continue the exposure, treat only one symptom, or delay reassessment leave the toxic process active.
References
1DailyMed: LINZESS (linaclotide)Severe diarrhea, dosing suspension, rehydration, hypotension, and electrolyte abnormalities